Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
People are getting their news from AI – and it’s altering their views - 2The Secret Destinations Amex Says Will Be More Popular Than Bali by 2026
- 3What really happens when 140 reality stars come face to face with their biggest fans
- 4Electric Vehicles for Eco-Accommodating Driving
- 5Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- The Force of Care: Living with Goal
- German finance minister seeks better market access in China talks
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- Paraplegic engineer becomes the first wheelchair user to blast into space
- Civil rights leader Jesse Jackson hospitalized, family requests prayers
- Experience Sports in Dubai: A Daredevil's Aide
- The most effective method to Guarantee Simple Availability in Seniors' SUVs
- 6 Financial plan 3D Printers with the Best Worth
- True to life Authenticity d: A Survey of \Certifiable Stories\ Narrative
